The Mid-Atlantic Bio Conference today announced that two industry-leading executives will deliver keynote addresses at the nationally recognized conference taking place on September 27-28 at the Bethesda North Marriott Hotel & Conference in Bethesda, Md.
Patrick J. Mahaffy, president and CEO of Boulder, Colorado-based Clovis Oncology, a biopharmaceutical company, will deliver opening remarks Thursday, September 27. Peter Greenleaf, president of MedImmune, the Gaithersburg, Maryland-based global biologics arm of AstraZeneca, will speak at the Conference’s closing luncheon Friday, September 28.
{iframe}http://www.marketwatch.com/story/medimmunes-greenleaf-clovis-oncologys-mahaffy-to-deliver-keynotes-at-2012-mid-atlantic-bio-conference-2012-08-13{/iframe}